Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Lee

Showing results (221-230 of 278) with videos related to

Pageof 28
Sort By:
Journal of Clinical Medicine|February 25, 2022
Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of SchizophreniaLorena García-Fernández, Verónica Romero-Ferreiro, Luis Sánchez-Pastor, et al.
Schizophrenia Bulletin|November 23, 2015
The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for PsychosisPaolo Fusar-Poli, Frauke Schultze-Lutter, Marco Cappucciati, et al.
Asian Journal of Psychiatry|November 7, 2025
Genetic signatures predict social-cognitive trajectories in ultra-high-risk psychosis: A 24-month longitudinal studyZohreh Doborjeh, Alexander Sumich, Oleg N Medvedev, et al.
Psychopharmacology|July 18, 2014
Proof-of-concept randomized controlled trial of pregnenolone in schizophreniaChristine E Marx, Jimmy Lee, Mythily Subramaniam, et al.
The Lancet Regional Health. Western Pacific|February 28, 2023
Adiposity impacts cognitive function in Asian populations: an epidemiological and Mendelian Randomization studyTheresia Mina, Yik Weng Yew, Hong Kiat Ng, et al.
Plos One|November 27, 2013
An evaluation of association between a novel hippocampal biology related SNP (rs7294919) and schizophreniaJiewei Liu, Shusuke Numata, Masashi Ikeda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 13, 2017
Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk StudyNew Fei Ho, Daphne J Holt, Mike Cheung, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Coronary Artery Disease Risk Variant rs6903956 Links to Endothelial Dysfunction via <i>PHACTR1</i> RegulationKai Yi Tay, Hannah Su-Ann Wee, Nhi Nguyen, et al.
Journal of Psychiatry & Neuroscience : JPN|April 17, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G Honer, Scott Clark, et al.
Journal of Psychiatry & Neuroscience : JPN|April 4, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G. Honer, Scott Clark, et al.
Pageof 28

Showing results (221-230 of 278) with videos related to

Sort By:
Pageof 28
Journal of Clinical Medicine|February 25, 2022
Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of SchizophreniaLorena García-Fernández, Verónica Romero-Ferreiro, Luis Sánchez-Pastor, et al.
Schizophrenia Bulletin|November 23, 2015
The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for PsychosisPaolo Fusar-Poli, Frauke Schultze-Lutter, Marco Cappucciati, et al.
Asian Journal of Psychiatry|November 7, 2025
Genetic signatures predict social-cognitive trajectories in ultra-high-risk psychosis: A 24-month longitudinal studyZohreh Doborjeh, Alexander Sumich, Oleg N Medvedev, et al.
Psychopharmacology|July 18, 2014
Proof-of-concept randomized controlled trial of pregnenolone in schizophreniaChristine E Marx, Jimmy Lee, Mythily Subramaniam, et al.
The Lancet Regional Health. Western Pacific|February 28, 2023
Adiposity impacts cognitive function in Asian populations: an epidemiological and Mendelian Randomization studyTheresia Mina, Yik Weng Yew, Hong Kiat Ng, et al.
Plos One|November 27, 2013
An evaluation of association between a novel hippocampal biology related SNP (rs7294919) and schizophreniaJiewei Liu, Shusuke Numata, Masashi Ikeda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 13, 2017
Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk StudyNew Fei Ho, Daphne J Holt, Mike Cheung, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Coronary Artery Disease Risk Variant rs6903956 Links to Endothelial Dysfunction via <i>PHACTR1</i> RegulationKai Yi Tay, Hannah Su-Ann Wee, Nhi Nguyen, et al.
Journal of Psychiatry & Neuroscience : JPN|April 17, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G Honer, Scott Clark, et al.
Journal of Psychiatry & Neuroscience : JPN|April 4, 2020
Consensus statement on the use of clozapine during the COVID-19 pandemicDan Siskind, William G. Honer, Scott Clark, et al.
Pageof 28